Thromboembolic stroke in young women: A European case-control study on oral contraceptives

Contraception

Volumn 57, Issue 1, 1998, Pages 29-37

  Heinemann, Lothar A J ^a,b,c,d   Lewis, Michael A ^e   Spitzer, Walter O ^f   Thorogood, Margaret ^g   Guggenmoos Holzmann, Irene ^a   Bruppacher, Rudolf ^d,h  

^a Assoc for Pharmacoepidemiology eV   (Germany)

^b Berlin Center for Epidemiology and Health Research   (Germany)

^c Potsdam Inst P   (Germany)

^d MCGILL UNIVERSITY   (Canada)

^e EPES Epidemiology   (Germany)

^f STANFORD UNIVERSITY   (United States)

^g LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^h UNIVERSITY OF BASEL   (Switzerland)

Author keywords

Cardiovascular risk factors; Case control study; Ischemic stroke; Oral contraceptives

Indexed keywords

CONCEPLAN; DESOGESTREL PLUS ETHINYLESTRADIOL; DIANE; DIENOGEST PLUS ETHINYLESTRADIOL; ETHINYLESTRADIOL PLUS ETYNODIOL DIACETATE; ETHINYLESTRADIOL PLUS GESTODENE; ETHINYLESTRADIOL PLUS LEVONORGESTREL; ETHINYLESTRADIOL PLUS LYNESTRENOL; ETHINYLESTRADIOL PLUS NORETHISTERONE; ETHINYLESTRADIOL PLUS NORETHISTERONE ACETATE; ETHINYLESTRADIOL PLUS NORGESTIMATE; LYNESTRENOL PLUS MESTRANOL; NEO EUNOMIN; NON OVLON; ORAL CONTRACEPTIVE AGENT; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ARTICLE; AUSTRIA; CASE CONTROL STUDY; CIGARETTE SMOKING; CLINICAL TRIAL; COHORT ANALYSIS; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FRANCE; GERMANY; HIGH RISK POPULATION; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; NUCLEAR MAGNETIC RESONANCE IMAGING; ORAL CONTRACEPTION; RISK ASSESSMENT; RISK FACTOR; STROKE; SWITZERLAND; THROMBOEMBOLISM; UNITED KINGDOM; WORLD HEALTH ORGANIZATION;

ADOLESCENT; ADULT; CASE-CONTROL STUDIES; COHORT STUDIES; CONFIDENCE INTERVALS; CONTRACEPTIVES, ORAL; FEMALE; HUMANS; INTRACRANIAL EMBOLISM AND THROMBOSIS; ODDS RATIO;

EID: 0031946619     PISSN: 00107824     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0010-7824(97)00204-7     Document Type: Article

References (32)

1. 1. Thorvaldsen P, Asplund K, Kuulasmaa K, Rajakangas AM, Schroll M, for the MONICA Project. Stroke incidence, case fatality, and mortality in the MONICA project. Stroke 1995;26:361-7.
2. 2. Stegmayr B. Stroke in the community. Studies on risk factors, incidence, case fatality, severity and secular trends in the northern Sweden MONICA Project, with multinational comparisons. Umea University Medical Dissertations. New Series No. 346-ISSN 6612-466, Umea, Sweden, 1996.
3. 3. Lorentz IT. Parietal lesion and Enovid. Br Med J 1962; 2:1191.
4. 4. Vessey MP, Doll R. Investigation of relation between use of oral contraceptives and thromboembolic disease. A further report. Br Med J 1969;2:651-7.
5. 5. Sartwell PE, Masi AT, Arthes FG, Green GR, Smith HE. Thromboembolism and oral contraceptives: an epidemiologic case-control study. Am J Epidemiol 1969;90: 365-80.
6. 6. Fogelholm R, Aho K. Ischaemic cerebrovascular disease in young adults. Acta Neurol Scand 1973;49:415-27.
7. 7. Jick H, Porter J, Rothman KJ. Oral contraceptives and non-fatal stroke in healthy young women. Ann Intern Med 1978;77:58-60.
8. 8. Thorogood M, Mann J, Murphy M, Vessey M. Fatal stroke and use of oral contraceptives: findings from a case-control study. Am J Epidemiol 1992;136:35-45.
9. 9. Lidegaard O. Oral contraception and risk of a cerebral thromboembolic attack: results of a case-control study. Br Med J 1993;306:956-63.
10. 10. Ramcharan S, Pelligrin FA, Ray R, Hsu JP. The Walnut Creek contraceptive study. Center for Population Research Monograph Number 81-564, Washington, D.C.: National Institutes of Health, 1981.
11. 11. Royal College of General Practitioners. Further analysis of mortality in oral contraceptive users. Lancet 1981; i.541-6.
12. 12. Layde PM, Ory HW, Beral V, Kay CR. Incidence of arterial disease among oral contraceptive users. J R Coll Gen Pract 1983;33:75-82.
13. 13. Vessey MP, Lawless M, Yeates D. Oral contraceptives and stroke: findings in a large prospective study. Br Med J 1984;289:530-1.
14. 14. Marmot M, Heinemann L. Orale Kontrazeptiva - Riosikofaktoren für Herz-Kreislauf-Ereignisse - zufällige Assoziation oder kausale Beziehung (in German). Z Ärztl Fortbild 1988;82:57-63.
15. 15. Heinemann L. Epidemiological assessment of cardiovascular effects of hormonal contraception. In: Michal, F, ed. Safety Requirements for Contraceptive Steroids. New York: Cambridge University Press, 1989:113-25.
16. 16. Heinemann L, Michal F. Internationale epidemiologische Studien zum kardiovaskulären Risiko hormonaler Kontrazeption (in German). Z Klin Med 1987;42: 2317-22.
17. 17. Spitzer WO, Lewis MA, Heinemann LAJ, Thorogood M, Mc Rae KD. Transnational Research Group on Oral Contraception and the Health of Young Women. Third generation oral contraceptives and risk of venous thromboembolic disorders: an international case-control study. Br Med J 1996;312:83-8.
18. 18. Lewis MA, Spitzer WO, Heinemann LAJ, McRae KD, Bruppacher R, Thorogood M, Transnational Research Group on Oral Contraception and the Health of Young Women. Third generation oral contraceptives and risk of myocardial infarction: an international case-control study. Br Med J 1996;312:88-90.
19. 19. Spitzer WO, Thorogood M, Heinemann L. Trinational case-control study of oral contraceptives and health. Pharmacoepidemiol Drug Safety 1993;2:21-31.
20. 20. Lewis MA, Assmann A, Heinemann L, Spitzer WO. Trinational case-control study of oral contraceptives and health. Approved protocol revision through September 1995. Pharmacoepidemiol Drug Saf 1996;5:43-51.
21. 21. World Health Organization. World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception. A multinational case-control study of cardiovascular disease and steroid hormone contraceptives. Description and validation of methods. J Clin Epidemiol 1995;48: 1513-47.
22. 22. STATA. Statistical software package, version 4.0. Stata Press, East Station, Texas.
23. 23. World Health Organization. WHO Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception. Ischaemic stroke and combined oral contraceptives: results of an international, multicentre, case-control study. Lancet 1996;348:498-505.
24. 24. Petitti DB, Sidney S, Bernstein A, Wolf S, Quesenberry C, Ziel HK. Stroke in users of low-dose oral contraceptives. N Engl J Med 1996;335:8-15.
25. 25. Collaborative Group for the Study of Stroke in Young Women. Oral contraceptives and stroke in young women. JAMA 1975;231:718-22.
26. 26. Inman WHW, Vessey MP. Investigation of deaths from pulmonary, coronary and cerebral thrombosis and embolism in women of child-bearing age. Br Med J 1968; 2:193-9.
27. 27. Collaborative Group for the Study of Stroke in Young Women. Oral contraception and increased risk of cerebral ischemia or thrombosis. N Eng J Med 1973;288: 871-8.
28. 28. Heinemann LAJ, Lewis MA, Assmann A, Gravens L, Guggenmoos-Holzmann I. Could preferential prescribing and referral behaviour of physicians explain the elevated thrombosis risk found to be associated with third generation oral contraceptives? Pharmacoepidemiol Drug Safety 1996;5:285-94.
29. 29. Heinemann LAJ. Haben Ovulationshemmer der dritten Generation ein anderes Risikoprofil? (Editorial) (in German). Deutsche Med Wochenschrift 1996;121: 1037-9.
30. 30. Heinemann LAJ. Background to epidemiology of the recent pill scare. In: Cohen J, ed. Oral Contraceptives and Cardiovascular Risk. Carnforth, New York: Parthenon Publishing, 1996:19-32.
31. 31. Vessey MP. Lessons learned from epidemiology. In: F Michal, ed. Safety Requirements for Contraceptive Steroids. New York: Cambridge University Press, 1989: 148-56.
32. 32. World Health Organization. Little risk of stroke for healthy young women using oral contraceptives. Prog Human Reprod Res 39:3-4.